GTx Enobosarm trial 1
A Phase II open label, multi-center, multinational, randomized, parallel design study investigating the efficacy and safety of GTx-024 on metastatic or locally advanced ER+/AR+ breast cancer in postmenopausal women.
A Phase II open label, multi-center, multinational, randomized, parallel design study investigating the efficacy and safety of GTx-024 on metastatic or locally advanced ER+/AR+ breast cancer in postmenopausal women.
Sorry, comments for this entry are closed at this time.